Bio-Rad Laboratories Inc (BIO.N)

BIO.N on New York Stock Exchange

31 Jul 2014
Price Change (% chg)

$-1.77 (-1.52%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for BIO.N


Bio-Rad Laboratories, Inc. (Bio-Rad), manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. Bio-Rad operates in two segments: Life... (more)


Beta: 1.23
Market Cap (Mil.): $3,327.07
Shares Outstanding (Mil.): 28.82
Dividend: --
Yield (%): --


  BIO.N Industry Sector
P/E (TTM): 52.27 31.94 36.20
EPS (TTM): 2.20 -- --
ROI: 2.15 9.70 18.07
ROE: 3.02 11.41 18.86
Search Stocks

CORRECTED-U.S. CDC recommends combo HIV test for faster detection of virus

(Corrects in paragraph 3 to show company making recommended test is Bio-Rad Laboratories, not Alere Inc)

27 Jun 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report
Provider: S&P Capital IQ Quantitative Report
Provider: MacroRisk Analytics/EconomicInvestor
Provider: MacroRisk Analytics/EconomicInvestor

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks